Rachel Klemovitch, Assistant Editor11.02.23
Many companies also received FDA clearances and released new study results. DePuy was the company to look for in October, with product developments and FDA nods.
DuPuy gained FDA nods on two products: TriLEAP Lower Extremity Plating System, and its TriALTID Technology. The company also began selling its VELYS robotic-assisted TKR in Europe, following successful surgeries in Belgium, Germany, and Switzerland.
THINK Surgical also received FDA 510k clearance for three knee replacement implants. ZKR Orthopedics gained FDA Breakthrough Device Designation Status for its knee replacement implant.
DuPuy gained FDA nods on two products: TriLEAP Lower Extremity Plating System, and its TriALTID Technology. The company also began selling its VELYS robotic-assisted TKR in Europe, following successful surgeries in Belgium, Germany, and Switzerland.
THINK Surgical also received FDA 510k clearance for three knee replacement implants. ZKR Orthopedics gained FDA Breakthrough Device Designation Status for its knee replacement implant.
- FDA OKs DePuy Synthes' TriLEAP Lower Extremity Plating System
- AMETEK to Purchase Paragon Medical for ~$2 Billion
- Biotronik Releases Promising BENEFIT-02 Trial Results for Prospera SCS
- DePuy Synthes' VELYS Robotic-Assisted TKR Enters European Market
- University of Arizona Startup Develops Comprehensive Orthopedic Hardware Removal Toolkit
- SpineX Shares Results of New Cerebral Palsy Therapies
- Tetrous Receives Patent for EnFix Family of Implants
- THINK Surgical's TMINI Robotic Handpiece OK'ed for 4 More Total Knee Implants
- DePuy Synthes Earns FDA Nod for TriALTIS Technology
- ZKR Ortho's LIFT Implant Granted FDA Breakthrough Status